Catherine Guillou and her group focus on the development of new methodologies, their application to the total synthesis of biologically active natural products and the design of enzyme inhibitors involved in cancer and Alzheimer’s disease. She is a co-author of 58 publications and 8 patents. Catherine Guillou and her group focus on the development of new methodologies, their application to the total synthesis of biologically active natural products and the design of enzyme inhibitors involved in cancer and Alzheimer’s disease. She is a co-author of 58 publications and 8 patents.
med